Washington Trust Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.62K | Hold |
109
| – | – | ﹤0.01% | 514 |
|
2025
Q1 | $8.01K | Hold |
109
| – | – | ﹤0.01% | 498 |
|
2024
Q4 | $7.14K | Buy |
109
+18
| +20% | +$1.18K | ﹤0.01% | 524 |
|
2024
Q3 | $7.09K | Sell |
91
-268
| -75% | -$20.9K | ﹤0.01% | 528 |
|
2024
Q2 | $28K | Buy |
359
+278
| +343% | +$21.7K | ﹤0.01% | 373 |
|
2024
Q1 | $5.49K | Hold |
81
| – | – | ﹤0.01% | 560 |
|
2023
Q4 | $5.46K | Buy |
+81
| New | +$5.46K | ﹤0.01% | 561 |
|
2023
Q2 | – | Sell |
-394
| Closed | -$27.3K | – | 673 |
|
2023
Q1 | $27.3K | Sell |
394
-346
| -47% | -$24K | ﹤0.01% | 378 |
|
2022
Q4 | $50.2K | Sell |
740
-1,111
| -60% | -$75.3K | 0.01% | 310 |
|
2022
Q3 | $102K | Buy |
1,851
+1,292
| +231% | +$71.2K | 0.01% | 275 |
|
2022
Q2 | $37K | Sell |
559
-958
| -63% | -$63.4K | ﹤0.01% | 442 |
|
2022
Q1 | $101K | Sell |
1,517
-251
| -14% | -$16.7K | 0.01% | 331 |
|
2021
Q4 | $103K | Buy |
+1,768
| New | +$103K | 0.01% | 357 |
|